Liraglutide can be used to treat diabetes
Goodman RE
Physiological status assessment Routine clinical biochemical analyses (blood count, blood biochemistry, C-reactive protein, homocysteine, cortisol, and coprological analysis) were performed by Olarte & Akle Bacteriologos in Mexico City, Mexico, following current quality standards
Giustarini D, Rossi R, Milzani A, Colombo R, Dalle-Donne I
The study results were published recently [48] and indicated that liraglutide did not improve clinical stability but was rather associated with a numerical but not statistically significant increase in the composite of death or HF hospitalization compared with placebo
For every 10,000 people taking GLP-1 medications for a year, roughly 25 more would experience DVT compared to those not taking the medication